CANF Quote, Trading Chart, Can-Fite Biopharma Ltd Sponsored ADR
home / stock / canf / canf quote
$2.29 Last:
4.09% Change Percent:
$2.19 Open:
$2.29 Previous Close:
$2.33 High:
$2.18 Low:
861,309 Volume:
06/24/2021 04:43:44 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CANF Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-24 | 2.19 | 2.29 | 2.33 | 2.18 | 861,309 |
| 2021-06-23 | 2.17 | 2.2 | 2.21 | 2.16 | 80,769 |
| 2021-06-22 | 2.22 | 2.16 | 2.25 | 2.11 | 163,054 |
| 2021-06-21 | 2.28 | 2.17 | 2.28 | 2.15 | 273,472 |
| 2021-06-18 | 2.3 | 2.28 | 2.3 | 2.21 | 180,189 |
| 2021-06-17 | 2.33 | 2.33 | 2.34 | 2.2401 | 305,932 |
| 2021-06-16 | 2.5 | 2.41 | 2.5 | 2.3 | 1,228,868 |
| 2021-06-15 | 2.61 | 2.48 | 2.62 | 2.29 | 9,978,579 |
| 2021-06-14 | 2.2 | 2.26 | 2.2899 | 2.18 | 139,975 |
| 2021-06-11 | 2.19 | 2.25 | 2.31 | 2.19 | 89,798 |
| 2021-06-10 | 2.16 | 2.23 | 2.24 | 2.15 | 389,606 |
| 2021-06-09 | 2.12 | 2.18 | 2.19 | 2.12 | 137,286 |
| 2021-06-08 | 2.17 | 2.17 | 2.2 | 2.15 | 113,281 |
| 2021-06-07 | 2.07 | 2.14 | 2.19 | 2.07 | 195,258 |
| 2021-06-04 | 2.1 | 2.09 | 2.12 | 2.06 | 95,708 |
| 2021-06-03 | 2.09 | 2.08 | 2.14 | 2.07 | 134,835 |
| 2021-06-02 | 2.11 | 2.11 | 2.16 | 2.07 | 312,451 |
| 2021-06-01 | 2.19 | 2.13 | 2.2 | 2.08 | 111,841 |
| 2021-05-31 | 2.06 | 2.16 | 2.21 | 2.04 | 449,505 |
| 2021-05-28 | 2.06 | 2.16 | 2.21 | 2.04 | 449,255 |
Can-Fite Biopharma Ltd Sponsored ADR Company Name:
CANF Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
-
Namodenoson is out-licensed in China for NASH, projected to become $6.4 billion market by 2027 Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, canc...
-
A prior Phase IIa clinical trial has been successfully concluded and met study end points Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer an...
-
Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced the Company’s Vice President of Business Development Dr. Sari Fis...